全球口蹄疫市场规模、份额、成长分析，按技术（传统疫苗（氢氧化铝/皂苷疫苗、油基疫苗）），按动物类型（牛、绵羊和山羊） - 行业预测 2024-2031

Global FMD Disease Market Size, Share, Growth Analysis, By Technique(Conventional Vaccines (Aluminum Hydroxide/Saponin-based Vaccines, Oil-based Vaccines)), By Animal Type(Cattle, Sheep and goat) - Industry Forecast 2024-2031

出版日期: 2024年04月06日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022 年，全球口蹄疫疾病市场规模为 23.9 亿美元，预计将从 2023 年的 25.8 亿美元成长到 2031 年的 48.2 亿美元，预测期内（2024-2031 年）复合年增长率为 8.1%。

由于对动物产品的需求增加和动物数量的增加，全球对兽用疫苗的采用，特别是那些旨在对抗口蹄疫（FMD）的疫苗，出现了显着增长。这种激增可归因于近年来受环境变迁和快速全球化等因素影响，牲畜和人畜共通传染病的盛行率上升。这些因素在推动兽用疫苗市场方面发挥了重要作用，因为世界各国政府优先考虑对各种动物（包括公共动物和牲畜物种）采取安全医疗实践。针对人畜共通病原体的立法在已开发国家和发展中国家均有效，并认识到疫情爆发对国家国内生产毛额 (GDP) 可能造成的严重经济后果。减轻这些风险的措施包括扑杀受感染的动物和保持足够的更新株的疫苗库存。在对牛奶、鸡蛋、肉类和织物等产品的需求不断增长的推动下，畜牧业呈现强劲增长，吸引了对先进机械和现代技术的大量投资。鑑于与疾病爆发相关的巨大经济损失，政府和畜牧业私人利益相关者认为针对口蹄疫的预防措施（例如疫苗接种）至关重要。缺乏明确的治癒方法凸显了疫苗接种的重要性，特别是考虑到感染可能透过多种方式发生。在畜牧业生产对 GDP 贡献显着的发展中国家，动物保健实践受到相当多的关注。这些国家的政府组织优先考虑开发新药物和疫苗接种计划，以保障牛隻的健康。相反，对动物流动采取严格措施和限制的地区，特别是北美和欧洲等富裕地区，有效地减少了口蹄疫的爆发，从而减少了对口蹄疫疫苗的依赖。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

MSD Animal Health
Zoetis
Boehringer Ingelheim
Bayer AG
Indian Immunologicals Ltd.
Biogenesis-Bago
Ceva SantA(C) Animale
China Animal Husbandry Co., Ltd. (CAH)
Guangdong Dahuanong Animal Health Products Co., Ltd.
Heska Corporation
Indian Immunologicals Limited
Lanzhou Veterinary Research Institute
Limor de Colombia SA
Merial (Sanofi)
Minnesota Veterinary Diagnostic Laboratory
PVT-Polish Veterinary Pharmaceuticals Ltd.
RAKARB Veterinary Biotech.
Vecol SA
VA(C)toquinol
Bioveta as

简介目录

Product Code: SQMIG35E2021

Global FMD disease market size was valued at USD 2.39 billion in 2022 and is poised to grow from USD 2.58 billion in 2023 to USD 4.82 billion by 2031, at a CAGR of 8.1% during the forecast period (2024-2031).

The global adoption of veterinary vaccines, particularly those aimed at combating Foot-and-Mouth Disease (FMD), has experienced significant growth due to the increased demand for animal products and a larger population of animals. This surge can be attributed to the heightened prevalence of livestock and zoonotic diseases in recent years, influenced by factors such as environmental changes and rapid globalization. These factors have played a substantial role in driving the veterinary vaccine market, as governments worldwide prioritize safe medical practices for various animals, including communal and livestock species. Legislation addressing zoonotic pathogens is in effect in both developed and developing nations, recognizing the potential severe economic consequences of an outbreak on a nation's gross domestic product (GDP). Measures to mitigate these risks include culling infected animals and maintaining adequate vaccine stockpiles with updated strains. The dynamic growth observed in the animal sector, driven by increasing demand for products such as milk, chicken eggs, meat, and fabric, has attracted significant investment in advanced machinery and modern technologies. Preventive measures against FMD, such as vaccination, are deemed crucial interventions by governments and private stakeholders in the animal industry, given the substantial financial losses associated with disease outbreaks. The absence of a definitive cure underscores the importance of vaccination, particularly considering the various means through which infection can occur. In developing countries where livestock production significantly contributes to GDP, animal healthcare practices receive considerable attention. Government organizations in these nations prioritize the development of new medications and vaccination programs to safeguard cattle health. Conversely, regions with stringent measures and restrictions on animal movement, particularly in affluent areas like North America and Europe, have effectively minimized FMD outbreaks and thus have reduced reliance on FMD vaccines.

Top-down and bottom-up approaches were used to estimate and validate the size of the global FMD disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global FMD Disease Market Segmental Analysis

The global FMD disease market is segmented based on technique, animal type, and region. By technique, the market is segmented into conventional vaccines (aluminum hydroxide/saponin-based vaccines, oil-based vaccines), and emergency vaccines. By animal type, the market is segmented into cattle, sheep and goat, pigs, others (antelope, deer, bison, and camelids). By region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global FMD Disease Market

The increasing demand for animal protein and dairy products serves as a significant catalyst for the Foot-and-Mouth Disease (FMD) market, given the potential for substantial losses within the livestock industry caused by FMD outbreaks.

Restraints in the Global FMD Disease Market

The substantial expenses associated with FMD vaccines and diagnostic tests represent a significant barrier to the FMD market, especially in developing nations with extensive livestock populations.

Market Trends of the Global FMD Disease Market

A prominent market trend is the rising demand for Foot-and-Mouth Disease (FMD) vaccines, especially evident in developing nations. Governments worldwide are implementing initiatives to mitigate and prevent FMD outbreaks, thereby fueling the demand for FMD vaccines.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global FMD Disease Market by Technique

Market Overview
Conventional Vaccines (Aluminum Hydroxide/Saponin-based Vaccines
Oil-based Vaccines)
and Emergency Vaccines

Global FMD Disease Market by Animal Type

Market Overview
Cattle
Sheep and goat
Pigs
and Others (antelope
deer
bison
and camelids)

Global FMD Disease Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

MSD Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoetis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indian Immunologicals Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogenesis-Bago
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ceva SantA(C) Animale
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
China Animal Husbandry Co., Ltd. (CAH)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guangdong Dahuanong Animal Health Products Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Heska Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indian Immunologicals Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lanzhou Veterinary Research Institute
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Limor de Colombia S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merial (Sanofi)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Minnesota Veterinary Diagnostic Laboratory
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PVT-Polish Veterinary Pharmaceuticals Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RAKARB Veterinary Biotech.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vecol S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VA(C)toquinol
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioveta a.s.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments